Yoko Nishikawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yoko Nishikawa has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Masamichi Hayashi
Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
2 shared publications - Mitsuhiro Hishida
Gastroenterological Surgery (Department of Surgery II), Graduate School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
2 shared publications - Mitsuro Kanda
Department of Gastroenterological Surgery Nagoya University Graduate School of Medicine Nagoya Japan
2 shared publications - Shin Takeda
Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan
2 shared publications - Shuji Nomoto
Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan
2 shared publications - Suguru Yamada
Department of Gastroenterological Surgery, Nagoya Central Hospital, Nagoya, Japan
2 shared publications
Latest Publications
- 10 June 2025
- Published by Springer Nature in Plant Ecology
- Vol. 226 (8) , 945-955
Impacts of invasive tall grass Miscanthus sinensis on coastal dune plant communities: a 17-year study in Northern Japan
- 10 June 2025
- Published by Springer Nature in Plant Ecology
- Vol. 226 (8) , 945-955
Impacts of invasive tall grass Miscanthus sinensis on coastal dune plant communities: a 17-year study in Northern Japan
- Open Access
- 10 January 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (2) , 181-188
Retrospective assessment of the availability of routine data related to the Amyotrophic Lateral Sclerosis Functional Rating Scale‐Revised in the electronic medical records of a university hospital
- 10 January 2021
- Published by Wiley in Neurology and Clinical Neuroscience
- Vol. 9 (2) , 181-188
Open AccessRetrospective assessment of the availability of routine data related to the Amyotrophic Lateral Sclerosis Functional Rating Scale‐Revised in the electronic medical records of a university hospital
- 30 May 2019
- Published by Springer Nature in Journal of Insect Conservation
- Vol. 23 (4) , 677-687
Habitat use and floral resource partitioning of native and alien bumblebees in the coastal grassland—rural landscape
- 30 May 2019
- Published by Springer Nature in Journal of Insect Conservation
- Vol. 23 (4) , 677-687
Habitat use and floral resource partitioning of native and alien bumblebees in the coastal grassland—rural landscape
- 31 December 2015
- Published by Springer Nature in Journal of Insect Conservation
- Vol. 20 (1) , 71-84
Effects of alien invasion by Bombus terrestris L. (Apidae) on the visitation patterns of native bumblebees in coastal plants in northern Japan
- 31 December 2015
- Published by Springer Nature in Journal of Insect Conservation
- Vol. 20 (1) , 71-84
Effects of alien invasion by Bombus terrestris L. (Apidae) on the visitation patterns of native bumblebees in coastal plants in northern Japan
- Open Access
- 19 February 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 108
Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related death especially among Asian and African populations. It is urgent that we identify carcinogenesis-related genes to establish an innovative treatment strategy for this disease.
- 19 February 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 108
Open AccessIdentification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the major causes of cancer-related death especially among Asian and African populations. It is urgent that we identify carcinogenesis-related genes to establish an innovative treatment strategy for this disease.
- Open Access
- 14 September 2013
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 32 (1) , 65
Detection of doublecortin domain-containing 2 (DCDC2), a new candidate tumor suppressor gene of hepatocellular carcinoma, by triple combination array analysis
Background: To detect genes correlated with hepatocellular carcinoma (HCC), we developed a triple combination array consisting of methylation array, gene expression array and single nucleotide polymorphism (SNP) array analysis. Methods: A surgical specimen obtained from a 68-year-old female HCC patient was analyzed by triple combination array, which identified doublecortin domain-containing 2 (DCDC2) as a candidate tumor suppressor gene of HCC. Subsequently, samples from 48 HCC patients were evaluated for their DCDC2 methylation and expression status using methylation specific PCR (MSP) and semi-quantitative reverse transcriptase (RT) PCR, respectively. Then, we investigated the relationship between clinicopathological factors and methylation status of DCDC2. Results: DCDC2 was revealed to be hypermethylated (methylation value 0.846, range 0–1.0) in cancer tissue, compared with adjacent normal tissue (0.212) by methylation array in the 68-year-old female patient. Expression array showed decreased expression of DCDC2 in cancerous tissue. SNP array showed that the copy number of chromosome 6p22.1, in which DCDC2 resides, was normal. MSP revealed hypermethylation of the promoter region of DCDC2 in 41 of the tumor samples. DCDC2 expression was significantly decreased in the cases with methylation (P = 0.048). Furthermore, the methylated cases revealed worse prognosis for overall survival than unmethylated cases (P = 0.048). Conclusions: The present study indicates that triple combination array is an effective method to detect novel genes related to HCC. We propose that DCDC2 is a tumor suppressor gene of HCC.
- 14 September 2013
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 32 (1) , 65
Open AccessDetection of doublecortin domain-containing 2 (DCDC2), a new candidate tumor suppressor gene of hepatocellular carcinoma, by triple combination array analysis
Background: To detect genes correlated with hepatocellular carcinoma (HCC), we developed a triple combination array consisting of methylation array, gene expression array and single nucleotide polymorphism (SNP) array analysis. Methods: A surgical specimen obtained from a 68-year-old female HCC patient was analyzed by triple combination array, which identified doublecortin domain-containing 2 (DCDC2) as a candidate tumor suppressor gene of HCC. Subsequently, samples from 48 HCC patients were evaluated for their DCDC2 methylation and expression status using methylation specific PCR (MSP) and semi-quantitative reverse transcriptase (RT) PCR, respectively. Then, we investigated the relationship between clinicopathological factors and methylation status of DCDC2. Results: DCDC2 was revealed to be hypermethylated (methylation value 0.846, range 0–1.0) in cancer tissue, compared with adjacent normal tissue (0.212) by methylation array in the 68-year-old female patient. Expression array showed decreased expression of DCDC2 in cancerous tissue. SNP array showed that the copy number of chromosome 6p22.1, in which DCDC2 resides, was normal. MSP revealed hypermethylation of the promoter region of DCDC2 in 41 of the tumor samples. DCDC2 expression was significantly decreased in the cases with methylation (P = 0.048). Furthermore, the methylated cases revealed worse prognosis for overall survival than unmethylated cases (P = 0.048). Conclusions: The present study indicates that triple combination array is an effective method to detect novel genes related to HCC. We propose that DCDC2 is a tumor suppressor gene of HCC.
- Open Access
- 1 January 2001
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 65 (8) , 1707-1712
Identification of 3,4-Dihydroxy-2-oxo-butanal (L-threosone) as an Intermediate Compound in Oxidative Degradation of Dehydro-L-ascorbic Acid and 2,3-Diketo-L-gulonic Acid in a Deuterium Oxide Phosphate Buffer
Dehydro-L-ascorbic acid (DAA), an oxidation product of L-ascorbic acid (vitamin C), is unstable in the neutral and basic pH regions. When DAA was incubated in a phosphate buffer with deuterium oxide (pH 7.4), it was degraded to form the main degradation compound, which was identified as 3,4-dihydroxy-2-oxobutanal (L-threosone). This compound was also formed from diketo-L-gulonic acid (DKG) in a phosphate buffer with deuterium oxide. L-threosone had reducing activity, probably due to its enolization, and is likely to have been involved in the formation of the reducing activity that was observed in aqueous DAA and DKG solutions. As a reactive dicarbonyl compound, L-threosone might also take some role in the cross-linking of tissue proteins that are formed in vivo in the Maillard reaction.
- 1 January 2001
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 65 (8) , 1707-1712
Open AccessIdentification of 3,4-Dihydroxy-2-oxo-butanal (L-threosone) as an Intermediate Compound in Oxidative Degradation of Dehydro-L-ascorbic Acid and 2,3-Diketo-L-gulonic Acid in a Deuterium Oxide Phosphate Buffer
Dehydro-L-ascorbic acid (DAA), an oxidation product of L-ascorbic acid (vitamin C), is unstable in the neutral and basic pH regions. When DAA was incubated in a phosphate buffer with deuterium oxide (pH 7.4), it was degraded to form the main degradation compound, which was identified as 3,4-dihydroxy-2-oxobutanal (L-threosone). This compound was also formed from diketo-L-gulonic acid (DKG) in a phosphate buffer with deuterium oxide. L-threosone had reducing activity, probably due to its enolization, and is likely to have been involved in the formation of the reducing activity that was observed in aqueous DAA and DKG solutions. As a reactive dicarbonyl compound, L-threosone might also take some role in the cross-linking of tissue proteins that are formed in vivo in the Maillard reaction.
- 1 January 2000
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 64 (8) , 1651-1655
Chemical characteristics of dehydro-L-ascorbic acid
Dehydro-L-ascorbic acid (DAA) exists mainly in its C2 hydrated bicyclic form (5) in an aqueous solution, and monocyclic DAA (3), which is the expected reaction product immediately after the oxidati...
- 1 January 2000
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 64 (8) , 1651-1655
Chemical characteristics of dehydro-L-ascorbic acid
Dehydro-L-ascorbic acid (DAA) exists mainly in its C2 hydrated bicyclic form (5) in an aqueous solution, and monocyclic DAA (3), which is the expected reaction product immediately after the oxidati...
- Open Access
- 1 July 1999
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 90 (7) , 720-725
Development and Distribution of 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]‐pyridine (PhIP)‐induced Aberrant Crypt Foci in the Rat Large Intestine
Aberrant crypt foci (ACF) are generally considered to be preneoplastic lesions for colon cancer. To assess their induction by 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP), a colon carcinogen, we performed a sequential study of ACF morphology and localization. F344 male rats were given PhIP, and methylene blue‐stained colon epithelium and isolated crypts were analyzed at weeks 12, 25, 50, and 75. Each crypt was classified into 2 groups, “single” with round bottoms and “bifurcating” displaying V‐shaped clefts (indicating proliferation). In combination with the number of crypts in an ACF, this classification was a good indicator for the generation of ACF in line with the fission mechanism of growth. Increasing numbers of crypts in ACF through weeks 12 to 75 and decreased percentages of ACF with bifurcating crypts at the late time points indicated that proliferation of crypts occurs predominantly during the early stages. The distribution pattern showed a significant shift (P < 0.000005) from the distal to the proximal part of the large intestine between weeks 25 and 50. Adenocarcinomas were first found to develop at week 50 in the ascending colon and cecum where bifurcating crypts were generally lacking at weeks 12 and 25. These data suggest the existence of (1) proliferating ACF which contains bifurcating crypt(s) and (2) quiescent or senescent ACF which consists of only single crypts.
- 1 July 1999
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 90 (7) , 720-725
Open AccessDevelopment and Distribution of 2‐Amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]‐pyridine (PhIP)‐induced Aberrant Crypt Foci in the Rat Large Intestine
Aberrant crypt foci (ACF) are generally considered to be preneoplastic lesions for colon cancer. To assess their induction by 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP), a colon carcinogen, we performed a sequential study of ACF morphology and localization. F344 male rats were given PhIP, and methylene blue‐stained colon epithelium and isolated crypts were analyzed at weeks 12, 25, 50, and 75. Each crypt was classified into 2 groups, “single” with round bottoms and “bifurcating” displaying V‐shaped clefts (indicating proliferation). In combination with the number of crypts in an ACF, this classification was a good indicator for the generation of ACF in line with the fission mechanism of growth. Increasing numbers of crypts in ACF through weeks 12 to 75 and decreased percentages of ACF with bifurcating crypts at the late time points indicated that proliferation of crypts occurs predominantly during the early stages. The distribution pattern showed a significant shift (P < 0.000005) from the distal to the proximal part of the large intestine between weeks 25 and 50. Adenocarcinomas were first found to develop at week 50 in the ascending colon and cecum where bifurcating crypts were generally lacking at weeks 12 and 25. These data suggest the existence of (1) proliferating ACF which contains bifurcating crypt(s) and (2) quiescent or senescent ACF which consists of only single crypts.